Jingxin Ye

Jingxin Ye

Auto-generated profile, based on publicly available information

Jingxin Ye

Department of Gastroenterology, The Affiliated Suqian Hospital of Xuzhou Medical University Suqian Jiangsu China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2024 in Exploration of Targeted Anti-tumor Therapy
Verified
Journal Article
Open access
PDF file
JYJingxin Ye
Jingxin Ye
JZJianfeng Zhang
Jianfeng Zhang
WDWeifeng Ding
Weifeng Ding
Colorectal cancer (CRC) is a multifaceted disease influenced by the interplay of genetic and environmental factors. The clinical heterogeneity of CRC cannot be attributed exclusively to genetic diversity and environmental exposures, and epigenetic markers, especially DNA methylation, play a critical role as key molecular markers of cancer. This review compiles a comprehensive body of evidence underscoring the significant involvement of DNA methylation modifications in the pathogenesis of CRC. Moreover, this review explores the potential utility of DNA methylation in cancer diagnosis, prognostics, assessment of disease activity, and prediction of drug responses. Recognizing the impact of DNA methylation will enhance the ability to identify distinct CRC subtypes, paving the way for personalized treatment strategies and advancing precision medicine in the management of CRC.

19 December 2025 in Medicine
Verified
Journal Article
Open access
JYJingxin Ye
Jingxin Ye
RCRenan Chang
Renan Chang
JZJianfeng Zhang
Jianfeng Zhang
FQFei Qian
Fei Qian
WDWeifeng Ding
Weifeng Ding
The highly polymorphic human major histocompatibility complex class I chain-related gene A (MICA) regulates immune surveillance and destroys tumor cells by activating its receptor, the natural killer group 2D. This study aimed to examine a single nucleotide polymorphism of this gene at codon 129 (MICA-129) in association with colorectal cancer (CRC). Using PCR sequencing, the MICA-129 polymorphism was examined in 104 patients with CRC and 536 healthy controls. Specific MICA-129 single nucleotide polymorphism was analyzed for its association with CRC susceptibility, clinical phenotypes, and selected CRC-associated microsatellite instability, driver gene mutation, immune checkpoint programmed death ligand 1, and diagnostic biomarkers carbohydrate antigen 19-9 and carcinoembryonic antigen. The MICA-129 heterozygous A/G (Met/Val) genotype was associated with less aggressive clinical characteristics, such as a reduced prevalence of the ulcerated subtype ( P = .0489, OR = 0.59) and lymph node involvement ( P = .0217, OR = 0.46). Conversely, the MICA-129 homozygous allele A/A (Met/Met) variant was related to more advanced clinical characteristics, such as increased tumor invasion depth (T3/4; P = .0261, OR = 2.10), driver gene mutation ( P = .0363, OR = 2.65), and KRAS mutation ( P = .0392, OR = 2.23). Additionally, patients with carbohydrate antigen 19-9-positive CRC had a lower MICA-129 Met/Val variation, whereas those with carcinoembryonic antigen-positive CRC had a higher MICA-129 Met/Met variant ( P = .0330/OR = 0.22 and P = .0034/OR = 2.99, respectively).

31 October 2025
Verified
Preprint
Open access
JYJingxin Ye
Jingxin Ye
FSFeng Su
Feng Su
JHJing Hou
Jing Hou
MYMengmeng Ye
Mengmeng Ye
ZNZilong Ni
Zilong Ni

7 April 2026 in Clinical Case Reports
Verified
Journal Article
Open access
JYJingxin Ye
Jingxin Ye
JHJing Hou
Jing Hou
ZNZilong Ni
Zilong Ni
MYMengmeng Ye
Mengmeng Ye
FSFeng Su
Feng Su
Langerhans cell histiocytosis (LCH) is an inflammatory neoplastic disease characterized by the clonal proliferation of Langerhans cells, with a very low incidence, mostly in children. LCH in adults is extremely rare, with esophageal involvement being particularly uncommon. Its insidious onset and nonspecific manifestations often lead to diagnostic challenges and delayed diagnosis. Endoscopy and endoscopic biopsy in LCH patients with gastrointestinal symptoms are important for diagnosis, monitoring, and treatment. During histopathological diagnosis, special attention should be paid to the differential diagnosis of LCH from common gastrointestinal malignancies. Herein, we report a rare case of isolated esophageal LCH in a 34‐year‐old adult, who underwent endoscopic resection with no recurrence during follow‐up.